IWM
MBIO icon

IHT Wealth Management’s Mustang Bio MBIO Stock Holding History

IHT Wealth Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22
Closed -$55K – 906
2021
Q2 		$55K Hold
22
– – ﹤0.01% 924
2021
Q1 		$55K Buy
22
+1
+5% +$2.97K ﹤0.01% 820
2020
Q4 		$59K Hold
21
– – ﹤0.01% 732
2020
Q3 		$49K Buy
+21
New +$51.8K ﹤0.01% 649
2020
Q2 		– Sell
-21
Closed -$42K – 612
2020
Q1 		$42K Hold
21
– – 0.01% 540
2019
Q4 		$63K Buy
21
+6
+40% +$13.7K 0.01% 609
2019
Q3 		$13K Buy
+15
New +$41K ﹤0.01% 608

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IHT Wealth Management's MBIO Position: Q3 2021 in Review

IHT Wealth Management sold out of Mustang Bio (MBIO) in Q3 2021, closing a stake of 22 shares — an estimated $55K sold.

IHT Wealth Management first reported a position in MBIO in Q3 2019 and held it in 7 quarters. The position peaked at $63K in Q4 2019. 79 funds tracked by Wall St. Rank hold MBIO as of Q3 2021.

  • IHT Wealth Management reported no remaining Mustang Bio position as of Q3 2021 after selling out during the quarter.
  • IHT Wealth Management sold 22 Mustang Bio shares in Q3 2021, an estimated $55K.
  • IHT Wealth Management first reported a position in Mustang Bio in Q3 2019 and held it in 7 quarters.
  • IHT Wealth Management's Mustang Bio position peaked at $63K in Q4 2019.
  • 79 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2021.

Based on IHT Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.